Skip to main content

Table 1 Baseline characteristics of patients with diabetic macular edema

From: Short-term effects of intravitreal ranibizumab therapy on diabetic macular edema

Age, years (mean ± SD)

62.9 ± 11.9

Men/women

8/6

Duration of diabetes (months, mean ± SD)

10.2 ± 7.6

DR scale (eyes)

NPDR 14

PDR 4

Hemoglobin A1c (%)

6.8 ± 0.5

History of photocoagulation (eyes)

14 (57%)

History of cataract surgery (eyes)

6 (33%)

VA (logMAR, mean ± SD)

0.41 ± 0.24

Baseline FT (microns, mean ± SD)

452 ± 77

  1. NPDR non-proliferative diabetic retinopathy, PDR proliferative diabetic retinopathy, logMAR logarithm of the minimum angle of resolution, SD standard deviation, VA visual acuity, FT foveal thickness